Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
10.09
+0.50 (5.21%)
Oct 19, 2026, 3:21 PM EDT - Market open
RGC Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 14.19 | 2.42 | 2.96 | 1.56 | 6.42 |
Short-Term Investments | - | 2.48 | 5 | 10 | 10 |
Cash & Short-Term Investments | 14.19 | 4.9 | 7.96 | 11.56 | 16.42 |
Cash Growth | 189.82% | -38.49% | -31.16% | -29.56% | 27532.00% |
Prepaid Expenses | 0.03 | 0.01 | 0.15 | 0.06 | 0.03 |
Total Current Assets | 14.22 | 4.9 | 8.11 | 11.62 | 16.44 |
Property, Plant & Equipment | 0.43 | 0.76 | 0.23 | 0.89 | 1.46 |
Other Long-Term Assets | 0.08 | 0.09 | 0.1 | 0.11 | 0.11 |
Total Assets | 14.73 | 5.76 | 8.44 | 12.62 | 18.02 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accrued Expenses | 1.07 | 0.35 | 0.13 | 0.16 | 0.15 |
Current Portion of Leases | 0.24 | 0.31 | 0.06 | 0.44 | 0.41 |
Other Current Liabilities | 0.01 | 0 | 0.01 | 0.01 | 0.02 |
Total Current Liabilities | 1.32 | 0.66 | 0.19 | 0.61 | 0.58 |
Long-Term Leases | 0.06 | 0.23 | 0.03 | 0.03 | 0.36 |
Total Liabilities | 1.38 | 0.9 | 0.22 | 0.63 | 0.94 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 50.29 | 30.12 | 29.88 | 29.43 | 28.51 |
Retained Earnings | -36.9 | -25.2 | -21.62 | -17.32 | -11.44 |
Comprehensive Income & Other | -0.05 | -0.06 | -0.05 | -0.09 | - |
Total Common Equity | 13.35 | 4.86 | 8.22 | 12.03 | 17.07 |
Minority Interest | - | - | - | -0.04 | 0.02 |
Shareholders' Equity | 13.35 | 4.86 | 8.22 | 11.99 | 17.08 |
Total Liabilities & Equity | 14.73 | 5.76 | 8.44 | 12.62 | 18.02 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 0.3 | 0.54 | 0.09 | 0.46 | 0.77 |
Net Cash (Debt) | 13.9 | 4.35 | 7.88 | 11.1 | 15.65 |
Net Cash Growth | 219.27% | -44.73% | -29.06% | -29.05% | - |
Net Cash Per Share | 0.03 | 0.01 | 0.02 | 0.02 | 0.03 |
Filing Date Shares Outstanding | 495.88 | 494.49 | 494.49 | 494.49 | 494.49 |
Total Common Shares Outstanding | 495.88 | 494.49 | 494.49 | 494.49 | 494.49 |
Working Capital | 12.9 | 4.24 | 7.92 | 11.01 | 15.87 |
Book Value Per Share | 0.03 | 0.01 | 0.02 | 0.02 | 0.03 |
Tangible Book Value | 13.35 | 4.86 | 8.22 | 12.03 | 17.07 |
Tangible Book Value Per Share | 0.03 | 0.01 | 0.02 | 0.02 | 0.03 |
Machinery | 0.45 | 0.45 | 0.3 | 0.3 | 0.3 |
Leasehold Improvements | 0.62 | 0.62 | 0.62 | 0.62 | 0.6 |